Shanghai, China

Xiaoxia Yan

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 13.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Xiaoxia Yan: Patents and Contributions to Medicine

Introduction: Xiaoxia Yan, an accomplished inventor based in Shanghai, China, has made significant contributions to the field of pharmaceuticals through his innovative research and development. With a total of two patents, his work focuses on compounds that may hold the key to treating various medical conditions.

Latest Patents: Xiaoxia Yan's latest patents revolve around Heterocyclic oxime compounds. These inventions relate to compounds of a specific formula (I) and their salts, designed for use in the treatment of both human and animal bodies. Particularly, these compounds target c-Met tyrosine kinase-mediated diseases or conditions. Furthermore, the invention details the utilization of these compounds for manufacturing a medicament intended to treat such diseases, alongside pharmaceutical compositions that may include a combination partner. The comprehensive processes for preparing such compounds are also included within the patent documentation.

Career Highlights: Currently, Xiaoxia Yan is associated with Novartis AG, where he continues to enhance his expertise and contribute to cutting-edge pharmaceutical developments. His experience in the industry underlines the importance of interdisciplinary collaboration in advancing medical science.

Collaborations: Within the ecosystem at Novartis AG, Xiaoxia Yan works alongside esteemed colleagues such as Miao Dai and Xingnian Fu. Their collaboration ensures a multidisciplinary approach to innovation, further propelling the exploration of new therapeutic possibilities.

Conclusion: Xiaoxia Yan stands out as a notable inventor whose work in Heterocyclic oxime compounds reflects a commitment to improving healthcare outcomes. His patents signify vital advancements in treating illnesses related to c-Met tyrosine kinase, showcasing the importance of inventive research in addressing contemporary medical challenges. Through his role at Novartis AG and collaborations with fellow innovators, Xiaoxia Yan’s contributions will undoubtedly continue to shape the future of pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…